The Wall Street Journal reported Monday evening that Moderna had sent vials to the National Institute of Allergy and Infectious Diseases in Bethesda, Md. The Institute told the Journal that it expects to start a clinical trial of 20 to 25 healthy volunteers b…
Read More
